2 Patents
- US122959482025Crenolanib for Treating FLT3 Mutated Proliferative Disorders Relapsed/refractory to Prior Treatment
Arog Pharmaceuticals, Inc.
0 cites - US118575462024Crenolanib for Treating FLT3 Mutated Proliferative Disorders Relapsed/refractory to Prior Treatment
AROG PHARMACEUTICALS, Inc.
0 cites